NASDAQ

Versartis Reports Fourth Quarter 2016 Financial Results

MENLO PARK, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused ...

CytomX Therapeutics to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

RedHill Biopharma Completes Treatment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis

Top-line results are expected in the second quarter of 2017  The randomized, double-blind, placebo-controlled Phase III study ...

RedHill Biopharma Completes Treatment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis

Top-line results are expected in the second quarter of 2017  The randomized, double-blind, placebo-controlled Phase III study ...